Robert Provenzano
#39,343
Most Influential Person Now
American Nephrologist
Robert Provenzano's AcademicInfluence.com Rankings
Robert Provenzanophilosophy Degrees
Philosophy
#9772
World Rank
#13378
Historical Rank
Logic
#8563
World Rank
#10732
Historical Rank
Download Badge
Philosophy
Why Is Robert Provenzano Influential?
(Suggest an Edit or Addition)According to Wikipedia, Robert Provenzano is an American nephrologist. He is also an Associate Clinical Professor of Medicine at Wayne State University School of Medicine. Affiliations Robert works with several professional societies and advisory boards. He is past-President of the Renal Physicians Association, immediate past-Chair of the Board of Trustees for the National Kidney Foundation of Michigan, and an active member of the American Society of Nephrology and the American Society of Transplantation, and a fellow of the American College of Physicians.
Robert Provenzano's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. (2016) (230)
- Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients (2015) (213)
- Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study. (2016) (205)
- Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. (2009) (172)
- Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007. (2007) (108)
- C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. (2008) (98)
- Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis. (2013) (98)
- Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study. (2005) (90)
- Epoetin alfa. Clinical evolution of a pleiotropic cytokine. (2004) (87)
- Peginesatide in patients with anemia undergoing hemodialysis. (2013) (83)
- CKD: common, harmful, and treatable--World Kidney Day 2007. (2007) (72)
- Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. (2004) (69)
- The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study. (2007) (60)
- Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa (2006) (55)
- Comparison of Vancomycin versus Cefazolin as Initial Therapy for Peritonitis in Peritoneal Dialysis Patients (2002) (45)
- C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis (2011) (44)
- Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. (2021) (41)
- Role of Aldosterone in Left Ventricular Hypertrophy among African-American Patients with End-Stage Renal Disease on Hemodialysis (2007) (34)
- Effect of biocompatibility of hemodialysis membranes on serum albumin levels. (2000) (32)
- Chronic Kidney Disease: Common, Harmful and Treatable – World Kidney Day 2007 (2007) (31)
- Pulmonary mucormycosis in diabetic renal allograft recipients. (1997) (28)
- Evaluation of Plasmapheresis in the Treatment of an Acute Overdose of Carbamazepine (1993) (27)
- Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis (2020) (27)
- The effect of cooled dialysate on thermal energy balance in hemodialysis patients. (1988) (26)
- Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD (2021) (24)
- Cyclosporine-induced renal macroangiopathy. (1988) (22)
- A single center experience in the use of polyurethaneurea arteriovenous grafts. (2005) (19)
- The nephrology nurse's role in improved care of patients with chronic kidney disease. (2002) (18)
- Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients. (2009) (18)
- Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG‐4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo‐Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients (2020) (18)
- Renal involvement in the acquired immunodeficiency syndrome: presentation, clinical course, and therapy. (1987) (15)
- Relationship among length of facility ownership, clinical performance, and mortality. (2010) (14)
- Spontaneous bilateral renal artery occlusion associated with chronic atrial fibrillation. (1993) (14)
- 212: FG2216, A Novel Oral HIF-PHI, Stimulates Erythropoiesis and Increases Hemoglobin Concentration in Patients with Non-Dialysis CKD (2008) (12)
- Insulin allergy resolution following pancreas transplantation alone. (1998) (12)
- Evaluation of Plasmapheresis on the Removal of Tobramycin (1995) (11)
- Extraskeletal Ewing's sarcoma in a kidney transplant patient. (1999) (11)
- Fibrillary glomerulonephritis in a renal allograft. (1998) (10)
- Two low-dose OKT3 induction regimens following renal transplantation--clinical experience at a single center. (1998) (9)
- 253 Evaluation of FG-4592, a Novel Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, to Treat Anemia in Hemodialysis Patients (2011) (8)
- Early detection of prostate cancer in the ESRD population. (2004) (8)
- Prevalence and treatment of anemia with once-weekly epoetin alfa in patients with diabetes and chronic kidney disease. (2006) (8)
- Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease. (2007) (7)
- Cordylancistrus perijae, a New Species of Armored Catfish (Siluroidei: Loricariidae) from the Maracaibo Basin, Venezuela (1996) (7)
- Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007. (2007) (7)
- Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease. (2008) (6)
- The Economics of Late-Stage Chronic Kidney Disease. (2016) (5)
- Chronic kidney disease: common, harmful and treatable—World Kidney Day 2007 (2007) (4)
- Anemia in Patients with Chronic Kidney Disease not on Dialysis : Results of a Randomized Clinical Trial (2008) (3)
- Treating chronic kidney disease. (2003) (2)
- Single-center analysis of the incidence of acute rejection in cadaveric renal allograft recipients induced with low-dose OKT3 with and without mycophenolate mofetil. (1999) (2)
- Treatment of CKD Anemia in Octogenarians: A Comparison of Epoetin Alfa (EPO) in Elderly (65–79; >/=80) and Non-Elderly (<65) Patients. (2004) (2)
- The value of integrating a vascular surgeon into a nephrology practice. (2003) (2)
- Management of Anemia (2018) (2)
- The species of Hemiancistrus (Siluriformes: Loricariidae) from Ecuador. (2017) (2)
- Renal anaemia - CKD 1-5 (2012) (1)
- Introduction: Role of the medical director series. (2015) (1)
- Effects of Frequent In-Center Hemodialysis: The Frequent Hemodialysis Network (FHN) Daily Trial (2010) (1)
- Prospective analysis of Hemodialysis Reliable Outflow (HeRO) vascular access graft vs. cuffed catheter access in hemodialysis. (2015) (1)
- Clinical Evolution of a Pleiotropic Cytokine (2017) (1)
- B-Natriuretic Peptide for the Prevention of Radiocontrast-Induced Nephropathy (2008) (1)
- 254 Pharmacokinetics of Oral FG-4592 to Treat Anemia in Hemodialysis (HD) Patients (PTS) (2011) (1)
- 136: Pilot Study of Brain Natriuretic Peptide (BNP) for the Prevention of Radiocontrast Induced Nephropathy (RCIN) After Cardiac Catheterization (2008) (0)
- Ef fi cacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non – Dialysis-Dependent CKD Pooled Results of Three Randomized Clinical Trials (2021) (0)
- 135: Nephrogenic Fibrosing Dermopathy (NFD): Case Series of 3 Patients in a Single Center (2008) (0)
- POS-258 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN THE POOLED PHASE 3 ROXADUSTAT STUDIES OF NON-DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE (2021) (0)
- Overview of dialysis patient management and future directions (2018) (0)
- Retraction notice to “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.” Kidney Int Rep. 2021;6:613–623 (2022) (0)
- Viewpoint: Is there a nephrologist shortage or just poor deployment? (2016) (0)
- AKI moves into the outpatient dialysis setting. What the new law means for patients, staff. (2017) (0)
- Paying fairly for good outcomes: which formula works? (2005) (0)
- THE IMPACT OF PERIPHERAL VASCULAR DISEASE ON PATIENT AND RENAL GRAFT SURVIVAL IN DIABETICS.: Abstract# 836 Poster Board #‐Session: P93‐III (2000) (0)
- CORE CURRICULUM IN NEPHROLOGY Economics of Clinical Nephrology Practice (2004) (0)
- Association of risk stratification score with dialysis vascular access stenosis. (2022) (0)
- 237: Frequency of HB Testing and Anemia Diagnosis in Patients with Chronic Kidney Disease During Pre and Postdialysis Period (2007) (0)
- 239: Hypertension Management Improved for In-Center Nocturnal Dialysis Patients Compared to Conventional Dialysis Patients (2010) (0)
- On Peginesatide and Anemia Treatment in CKD (2013) (0)
- POS-284 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN POOLED PHASE 3 TRIALS OF ROXADUSTAT IN DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE (2021) (0)
- Economics of clinical nephrology practice. (2004) (0)
- Survival of Patients with Preexisting Coronary Artery Disease (CAD) Following Kidney or Kidney/Pancreas Transplantation with (1998) (0)
- Anemia of Chronic Kidney Disease (2018) (0)
- Single Center Analysis of the Incidence of Acute Rejection in Cadaver Renal Allograft Recipients Induced with Low Dose OKT3 with and without Mycofenalate Mofetil (MMF) (1998) (0)
- 58: Nephrogenic Fibrosing Dermopathy (NFD) in a Patient With Acute Kidney Injury (AKI) (2008) (0)
- Pilot study of B-natriuretic peptide for the prevention of radiocontrast-induced nephropathy after cardiac catheterization (2008) (0)
- 182: In-Center Nocturnal Hemodialysis Leads to Improved Serum Phosphorus (PO4) Levels (2010) (0)
- Microperimetric Outcomes After 25-G Pars Plana Vitrectomy for Stage III/IV Macular Hole: A Prospective Study (2010) (0)
- LAPAROSCOPIC LIVE DONOR NEPHRECTOMY: MINIMIZING LEARNING CURVE.: Abstract# 854 Poster Board #‐Session: P111‐III (2000) (0)
This paper list is powered by the following services:
Other Resources About Robert Provenzano
What Schools Are Affiliated With Robert Provenzano?
Robert Provenzano is affiliated with the following schools:
